April 28, 2023 02:11 PM EDT
Pharma
Marketing

Pre­scrip­tion re­fills help fu­el tele­health's stay­ing pow­er as pan­dem­ic wanes

Beth Snyder Bulik

Senior Editor

Tele­health may have surged dur­ing the Covid-19 pan­dem­ic, but it looks like it’s now here to stay. New re­search from point-of-care com­pa­ny Phree­sia finds that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times